New opportunities for nanoparticles in cancer immunotherapy
Abstract Background Recently, cancer immunotherapy has become standard for cancer treatment.Immunotherapy not only PEPPERMINT treats primary tumors, but also prevents metastasis and recurrence, representing a major advantage over conventional cancer treatments.However, existing cancer immunotherapies have limited clinical benefits because cancer an